Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion type Assertion NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_head.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion description "[By combining affinity proteomics and gene expression analysis, we now propose superoxide dismutase 1 (SOD1) as the most likely target of one of these small molecules, referred to as lung cancer screen 1 (LCS-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_provenance.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion evidence source_evidence_literature NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_provenance.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion SIO_000772 21930909 NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_provenance.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion wasDerivedFrom befree-2016 NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_provenance.
- NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_assertion wasGeneratedBy ECO_0000203 NP924829.RA5x8nxO6cxs06A6HvUUBy2f14nKs6BMKlDZWTMxdVAvM130_provenance.